You have 9 free searches left this month | for more free features.

Houston (1)

Kashiwa (1)

Shizuoka (1)

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available (1)

Solid Tumors (1)

Completed (2)

phase 1 (2)

EMD Serono (1)

Merck KGaA, Darmstadt, Germany (1)

Merck KGaA, Darmstadt, Germany (1)

msc2156119j (2)

drug (2)

Industry (2)

Interventional (2)

msc2156119j

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

Aug 22, 2022

Completed

Jul 23, 2020